| Deep brain stimulation for treatment-resistant depression: efficacy, safety and mechanisms of action RJ Anderson, MA Frye, OA Abulseoud, KH Lee, JA McGillivray, M Berk, ... Neuroscience & Biobehavioral Reviews 36 (8), 1920-1933, 2012 | 188 | 2012 |
| Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compass J Davis, M Maes, A Andreazza, JJ McGrath, SJ Tye, M Berk Molecular psychiatry 20 (2), 152-153, 2015 | 186 | 2015 |
| A model of the mitochondrial basis of bipolar disorder G Morris, K Walder, SL McGee, OM Dean, SJ Tye, M Maes, M Berk Neuroscience & Biobehavioral Reviews 74, 1-20, 2017 | 153 | 2017 |
| Ketamine for treatment‐resistant unipolar and bipolar major depression: Critical review and implications for clinical practice WV Bobo, JL Vande Voort, PE Croarkin, JG Leung, SJ Tye, MA Frye Depression and anxiety 33 (8), 698-710, 2016 | 126 | 2016 |
| Continuation phase intravenous ketamine in adults with treatment-resistant depression JLV Voort, RJ Morgan, S Kung, KG Rasmussen, J Rico, BA Palmer, ... Journal of affective disorders 206, 300-304, 2016 | 110 | 2016 |
| Intravenous ketamine for adolescents with treatment-resistant depression: an open-label study KR Cullen, P Amatya, MG Roback, CS Albott, M Westlund Schreiner, ... Journal of child and adolescent psychopharmacology 28 (7), 437-444, 2018 | 92 | 2018 |
| Wireless Instantaneous Neurotransmitter Concentration System–based amperometric detection of dopamine, adenosine, and glutamate for intraoperative neurochemical monitoring F Agnesi, SJ Tye, JM Bledsoe, CJ Griessenauer, CJ Kimble, GC Sieck, ... Journal of neurosurgery 111 (4), 701-711, 2009 | 91 | 2009 |
| A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression PR Shiroma, P Thuras, J Wels, CS Albott, C Erbes, S Tye, KO Lim Translational psychiatry 10 (1), 206, 2020 | 87 | 2020 |
| Concomitant benzodiazepine use attenuates ketamine response: implications for large scale study design and clinical development MA Frye, P Blier, SJ Tye Journal of clinical psychopharmacology 35 (3), 334-336, 2015 | 84 | 2015 |
| Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literature A Chopra, SJ Tye, KH Lee, S Sampson, J Matsumoto, A Adams, ... The Journal of neuropsychiatry and clinical neurosciences 24 (1), 102-110, 2012 | 82 | 2012 |
| Disrupting disordered neurocircuitry: treating refractory psychiatric illness with neuromodulation SJ Tye, MA Frye, KH Lee Mayo Clinic Proceedings 84 (6), 522-532, 2009 | 82 | 2009 |
| How well do we understand the long-term health implications of childhood bullying? PP Zarate-Garza, BK Biggs, P Croarkin, B Morath, J Leffler, ... Harvard review of psychiatry 25 (2), 89-95, 2017 | 81 | 2017 |
| A miniature energy harvesting rectenna for operating a head-mountable deep brain stimulation device MK Hosain, AZ Kouzani, MF Samad, SJ Tye IEEE access 3, 223-234, 2015 | 78 | 2015 |
| Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders MA Frye, M Nassan, GD Jenkins, S Kung, M Veldic, BA Palmer, ... Translational psychiatry 5 (12), e689-e689, 2015 | 77 | 2015 |
| Fostering resilience among mothers under stress:“Authentic connections groups” for medical professionals SS Luthar, A Curlee, SJ Tye, JC Engelman, CM Stonnington Women's Health Issues 27 (3), 382-390, 2017 | 76 | 2017 |
| Closed loop deep brain stimulation: an evolving technology MK Hosain, A Kouzani, S Tye Australasian physical & engineering sciences in medicine 37, 619-634, 2014 | 75 | 2014 |
| Stress, inflammation, and cellular vulnerability during early stages of affective disorders: biomarker strategies and opportunities for prevention and intervention AJ Walker, Y Kim, JB Price, RP Kale, JA McGillivray, M Berk, SJ Tye Frontiers in psychiatry 5, 34, 2014 | 71 | 2014 |
| Comonitoring of adenosine and dopamine using the Wireless Instantaneous Neurotransmitter Concentration System: proof of principle YM Shon, SY Chang, SJ Tye, CJ Kimble, KE Bennet, CD Blaha, KH Lee Journal of neurosurgery 112 (3), 539-548, 2010 | 61 | 2010 |
| Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistance AJ Walker, BM Foley, SL Sutor, JA McGillivray, MA Frye, SJ Tye Behavioural brain research 293, 198-202, 2015 | 59 | 2015 |
| Wireless Instantaneous Neurotransmitter Concentration System: electrochemical monitoring of serotonin using fast-scan cyclic voltammetry—a proof-of-principle study CJ Griessenauer, SY Chang, SJ Tye, CJ Kimble, KE Bennet, PA Garris, ... Journal of neurosurgery 113 (3), 656-665, 2010 | 59 | 2010 |
Michael BerkDeakin UniversityVerified email at deakin.edu.au